Lataa...
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
With advances in molecular biologic and genomic technology, detailed molecular mechanisms for development of castration-resistant prostate cancer (CRPC) have surfaced. Metastatic prostate cancer (PCa) no longer represents an end stage, with many emerging therapeutic agents approved as effective in p...
Tallennettuna:
| Julkaisussa: | Biomedicine (Taipei) |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
China Medical University
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4264971/ https://ncbi.nlm.nih.gov/pubmed/25520915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7603/s40681-014-0002-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|